Diamond BiofundTPE:6901 +9.86%16 PB Ratio is 1.75 as of Jun. 26, 2026. GuruFocus rates TPE:6901 with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 1,604 Asset Management companies, Diamond Biofund ranks worse than 82.73% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Diamond Biofund's share price is NT$18.95. Diamond Biofund's Book Value per Share for the quarter that ended in Dec. 2025 was NT$10.81. Hence, Diamond Biofund's PB Ratio of today is 1.75.
The historical rank and industry rank for Diamond Biofund's PB Ratio or its related term are showing as below:
TPE:6901'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 1.75
Current: 1.75
During the past 7 years, Diamond Biofund's highest PB Ratio was 1.75. The lowest was 0.00. And the median was 0.00.
TPE:6901's PB Ratio is ranked worse than 82.73% of 1604
companies
in the Asset Management industry
Industry Median: 0.95
vs TPE:6901: 1.75
During the past 12 months, Diamond Biofund's average Book Value Per Share Growth Rate was -11.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -9.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -2.70% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Diamond Biofund was 54.30% per year. The lowest was -9.80% per year. And the median was 1.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Diamond Biofund PB Ratio Related Terms
Diamond Biofund PB Ratio Historical Data
* Premium members only.
The historical data trend for Diamond Biofund's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Diamond Biofund's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diamond Biofund PB Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Diamond Biofund's PB Ratio distribution charts can be found below:
* The bar in red indicates where Diamond Biofund's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Diamond Biofund's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Diamond Biofund (TPE:6901) has a PB Ratio of 1.75 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Diamond Biofund and its competitors. According to the industry distribution chart, Diamond Biofund ranks #1327 out of 1604 companies in the Asset Management industry, placing it in the top 82.7%.
Is Diamond Biofund's PB Ratio too high?
Diamond Biofund's current PB Ratio is 1.75. The Asset Management industry median PB Ratio is 0.95. Diamond Biofund's value of 1.75 is 84.2% above this industry median. Based on the distribution chart, Diamond Biofund ranks #1327 out of 1604 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Diamond Biofund has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's PB Ratio compare to BLK and BX?
According to the Asset Management industry distribution chart, Diamond Biofund ranks #1327 out of 1604 companies for PB Ratio. This places Diamond Biofund in the lower half of its industry. The industry median PB Ratio is 0.95. Diamond Biofund's value of 1.75 is 84.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Asset Management company?
The median PB Ratio among Asset Management companies is 0.95, based on 1,604 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diamond Biofund's current PB Ratio of 1.75 is 84.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Diamond Biofund and its competitors. For the Asset Management industry, the median PB Ratio is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diamond Biofund's current PB Ratio is 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current PB Ratio of 1.75. The current PB Ratio is 1.75 and 84.2% above the Asset Management industry median of 0.95. Diamond Biofund's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current PB Ratio is 1.75 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
16GF Score
Get the complete analysis for TPE:6901
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6901 has been successfully added to your 
